The present study revealed that serum syndecan-1 concentration: 1) was higher in patients with heart failure than in healthy subjects from previous reports [33], 2) responded promptly to treatment against heart failure, and 3) might predict readmission-free survival in patients with heart failure. This evidence concerns the gene SDC1 and heart failure.